Phenotyping animal models of diabetic neuropathy: A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)

G. J. Biessels, V. Bril, N. A. Calcutt, N. E. Cameron, M. A. Cotter, R. Dobrowsky, E. L. Feldman, P. Fernyhough, J. Jakobsen, Rayaz Malik, A. P. Mizisin, P. J. Oates, I. G. Obrosova, R. Pop-Busui, J. W. Russell, A. A. Sima, M. J. Stevens, R. E. Schmidt, S. Tesfaye, A. VevesA. I. Vinik, D. E. Wright, S. Yagihashi, M. A. Yorek, D. Ziegler, D. W. Zochodne

Research output: Contribution to journalReview article

54 Citations (Scopus)

Abstract

NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to explore the current status of animal models of diabetic peripheral neuropathy. The goal of the workshop was to develop a set of consensus criteria for the phenotyping of rodent models of diabetic neuropathy. The discussion was divided into five areas: (1) status of commonly used rodent models of diabetes, (2) nerve structure, (3) electrophysiological assessments of nerve function, (4) behavioral assessments of nerve function, and (5) the role of biomarkers in disease phenotyping. Participants discussed the current understanding of each area, gold standards (if applicable) for assessments of function, improvements of existing techniques, and utility of known and exploratory biomarkers. The research opportunities in each area were outlined, providing a possible roadmap for future studies. The meeting concluded with a discussion on the merits and limitations of a unified approach to phenotyping rodent models of diabetic neuropathy and a consensus formed on the definition of the minimum criteria required for establishing the presence of the disease. A neuropathy phenotype in rodents was defined as the presence of statistically different values between diabetic and control animals in 2 of 3 assessments (nocifensive behavior, nerve conduction velocities, or nerve structure). The participants propose that this framework would allow different research groups to compare and share data, with an emphasis on data targeted toward the therapeutic efficacy of drug interventions.

Original languageEnglish
Pages (from-to)77-87
Number of pages11
JournalJournal of the Peripheral Nervous System
Volume19
Issue number2
DOIs
Publication statusPublished - 1 Jun 2014
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Rodentia
Consensus
Animal Models
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Biomarkers
Neural Conduction
Peripheral Nervous System Diseases
Research
Type 2 Diabetes Mellitus
Phenotype
Education
Pharmaceutical Preparations
Therapeutics

Keywords

  • Diabetes
  • Diabetic neuropathy
  • Neuropathy
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Phenotyping animal models of diabetic neuropathy : A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). / Biessels, G. J.; Bril, V.; Calcutt, N. A.; Cameron, N. E.; Cotter, M. A.; Dobrowsky, R.; Feldman, E. L.; Fernyhough, P.; Jakobsen, J.; Malik, Rayaz; Mizisin, A. P.; Oates, P. J.; Obrosova, I. G.; Pop-Busui, R.; Russell, J. W.; Sima, A. A.; Stevens, M. J.; Schmidt, R. E.; Tesfaye, S.; Veves, A.; Vinik, A. I.; Wright, D. E.; Yagihashi, S.; Yorek, M. A.; Ziegler, D.; Zochodne, D. W.

In: Journal of the Peripheral Nervous System, Vol. 19, No. 2, 01.06.2014, p. 77-87.

Research output: Contribution to journalReview article

Biessels, GJ, Bril, V, Calcutt, NA, Cameron, NE, Cotter, MA, Dobrowsky, R, Feldman, EL, Fernyhough, P, Jakobsen, J, Malik, R, Mizisin, AP, Oates, PJ, Obrosova, IG, Pop-Busui, R, Russell, JW, Sima, AA, Stevens, MJ, Schmidt, RE, Tesfaye, S, Veves, A, Vinik, AI, Wright, DE, Yagihashi, S, Yorek, MA, Ziegler, D & Zochodne, DW 2014, 'Phenotyping animal models of diabetic neuropathy: A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)', Journal of the Peripheral Nervous System, vol. 19, no. 2, pp. 77-87. https://doi.org/10.1111/jns5.12072
Biessels, G. J. ; Bril, V. ; Calcutt, N. A. ; Cameron, N. E. ; Cotter, M. A. ; Dobrowsky, R. ; Feldman, E. L. ; Fernyhough, P. ; Jakobsen, J. ; Malik, Rayaz ; Mizisin, A. P. ; Oates, P. J. ; Obrosova, I. G. ; Pop-Busui, R. ; Russell, J. W. ; Sima, A. A. ; Stevens, M. J. ; Schmidt, R. E. ; Tesfaye, S. ; Veves, A. ; Vinik, A. I. ; Wright, D. E. ; Yagihashi, S. ; Yorek, M. A. ; Ziegler, D. ; Zochodne, D. W. / Phenotyping animal models of diabetic neuropathy : A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). In: Journal of the Peripheral Nervous System. 2014 ; Vol. 19, No. 2. pp. 77-87.
@article{6aeea685a38e481889fdd4824db8aa55,
title = "Phenotyping animal models of diabetic neuropathy: A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)",
abstract = "NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to explore the current status of animal models of diabetic peripheral neuropathy. The goal of the workshop was to develop a set of consensus criteria for the phenotyping of rodent models of diabetic neuropathy. The discussion was divided into five areas: (1) status of commonly used rodent models of diabetes, (2) nerve structure, (3) electrophysiological assessments of nerve function, (4) behavioral assessments of nerve function, and (5) the role of biomarkers in disease phenotyping. Participants discussed the current understanding of each area, gold standards (if applicable) for assessments of function, improvements of existing techniques, and utility of known and exploratory biomarkers. The research opportunities in each area were outlined, providing a possible roadmap for future studies. The meeting concluded with a discussion on the merits and limitations of a unified approach to phenotyping rodent models of diabetic neuropathy and a consensus formed on the definition of the minimum criteria required for establishing the presence of the disease. A neuropathy phenotype in rodents was defined as the presence of statistically different values between diabetic and control animals in 2 of 3 assessments (nocifensive behavior, nerve conduction velocities, or nerve structure). The participants propose that this framework would allow different research groups to compare and share data, with an emphasis on data targeted toward the therapeutic efficacy of drug interventions.",
keywords = "Diabetes, Diabetic neuropathy, Neuropathy, Peripheral neuropathy",
author = "Biessels, {G. J.} and V. Bril and Calcutt, {N. A.} and Cameron, {N. E.} and Cotter, {M. A.} and R. Dobrowsky and Feldman, {E. L.} and P. Fernyhough and J. Jakobsen and Rayaz Malik and Mizisin, {A. P.} and Oates, {P. J.} and Obrosova, {I. G.} and R. Pop-Busui and Russell, {J. W.} and Sima, {A. A.} and Stevens, {M. J.} and Schmidt, {R. E.} and S. Tesfaye and A. Veves and Vinik, {A. I.} and Wright, {D. E.} and S. Yagihashi and Yorek, {M. A.} and D. Ziegler and Zochodne, {D. W.}",
year = "2014",
month = "6",
day = "1",
doi = "10.1111/jns5.12072",
language = "English",
volume = "19",
pages = "77--87",
journal = "Journal of the Peripheral Nervous System",
issn = "1085-9489",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Phenotyping animal models of diabetic neuropathy

T2 - A consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)

AU - Biessels, G. J.

AU - Bril, V.

AU - Calcutt, N. A.

AU - Cameron, N. E.

AU - Cotter, M. A.

AU - Dobrowsky, R.

AU - Feldman, E. L.

AU - Fernyhough, P.

AU - Jakobsen, J.

AU - Malik, Rayaz

AU - Mizisin, A. P.

AU - Oates, P. J.

AU - Obrosova, I. G.

AU - Pop-Busui, R.

AU - Russell, J. W.

AU - Sima, A. A.

AU - Stevens, M. J.

AU - Schmidt, R. E.

AU - Tesfaye, S.

AU - Veves, A.

AU - Vinik, A. I.

AU - Wright, D. E.

AU - Yagihashi, S.

AU - Yorek, M. A.

AU - Ziegler, D.

AU - Zochodne, D. W.

PY - 2014/6/1

Y1 - 2014/6/1

N2 - NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to explore the current status of animal models of diabetic peripheral neuropathy. The goal of the workshop was to develop a set of consensus criteria for the phenotyping of rodent models of diabetic neuropathy. The discussion was divided into five areas: (1) status of commonly used rodent models of diabetes, (2) nerve structure, (3) electrophysiological assessments of nerve function, (4) behavioral assessments of nerve function, and (5) the role of biomarkers in disease phenotyping. Participants discussed the current understanding of each area, gold standards (if applicable) for assessments of function, improvements of existing techniques, and utility of known and exploratory biomarkers. The research opportunities in each area were outlined, providing a possible roadmap for future studies. The meeting concluded with a discussion on the merits and limitations of a unified approach to phenotyping rodent models of diabetic neuropathy and a consensus formed on the definition of the minimum criteria required for establishing the presence of the disease. A neuropathy phenotype in rodents was defined as the presence of statistically different values between diabetic and control animals in 2 of 3 assessments (nocifensive behavior, nerve conduction velocities, or nerve structure). The participants propose that this framework would allow different research groups to compare and share data, with an emphasis on data targeted toward the therapeutic efficacy of drug interventions.

AB - NIDDK, JDRF, and the Diabetic Neuropathy Study Group of EASD sponsored a meeting to explore the current status of animal models of diabetic peripheral neuropathy. The goal of the workshop was to develop a set of consensus criteria for the phenotyping of rodent models of diabetic neuropathy. The discussion was divided into five areas: (1) status of commonly used rodent models of diabetes, (2) nerve structure, (3) electrophysiological assessments of nerve function, (4) behavioral assessments of nerve function, and (5) the role of biomarkers in disease phenotyping. Participants discussed the current understanding of each area, gold standards (if applicable) for assessments of function, improvements of existing techniques, and utility of known and exploratory biomarkers. The research opportunities in each area were outlined, providing a possible roadmap for future studies. The meeting concluded with a discussion on the merits and limitations of a unified approach to phenotyping rodent models of diabetic neuropathy and a consensus formed on the definition of the minimum criteria required for establishing the presence of the disease. A neuropathy phenotype in rodents was defined as the presence of statistically different values between diabetic and control animals in 2 of 3 assessments (nocifensive behavior, nerve conduction velocities, or nerve structure). The participants propose that this framework would allow different research groups to compare and share data, with an emphasis on data targeted toward the therapeutic efficacy of drug interventions.

KW - Diabetes

KW - Diabetic neuropathy

KW - Neuropathy

KW - Peripheral neuropathy

UR - http://www.scopus.com/inward/record.url?scp=84925351546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925351546&partnerID=8YFLogxK

U2 - 10.1111/jns5.12072

DO - 10.1111/jns5.12072

M3 - Review article

C2 - 24934510

AN - SCOPUS:84925351546

VL - 19

SP - 77

EP - 87

JO - Journal of the Peripheral Nervous System

JF - Journal of the Peripheral Nervous System

SN - 1085-9489

IS - 2

ER -